Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report)’s stock price rose 2.3% during trading on Monday . The stock traded as high as $344.81 and last traded at $344.81. Approximately 11 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 905 shares. The stock had previously closed at $337.08.
Bio-Rad Laboratories Stock Down 3.3 %
The company has a debt-to-equity ratio of 0.16, a quick ratio of 4.52 and a current ratio of 6.14. The stock has a market cap of $9.12 billion, a price-to-earnings ratio of -11.92 and a beta of 0.72. The business’s 50 day moving average is $336.39 and its 200 day moving average is $317.98.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Read More
- Five stocks we like better than Bio-Rad Laboratories
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- How to Use Stock Screeners to Find Stocks
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- NYSE Stocks Give Investors a Variety of Quality Options
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
